Skip to main content

previous disabled Page of 4
and
  1. No Access

    Chapter

    Lung-on-a-Chip Models of the Lung Parenchyma

    Since the publication of the first lung-on-a-chip in 2010, research has made tremendous progress in mimicking the cellular environment of healthy and diseased alveoli. As the first lung-on-a-chip products have...

    Pauline Zamprogno, Jan Schulte in Engineering Translational Models of Lung H… (2023)

  2. No Access

    Chapter

    Acute and Chronic Wound Management: Assessment, Therapy and Monitoring Strategies

    The dynamic nature of the wound healing is a well-studied process. With the rapid evolution of healthcare science, efforts are being made to design newer therapies, along with advancement in the available tech...

    Anisha Kabir, Anwita Sarkar, Ananya Barui in Regenerative Medicine (2023)

  3. No Access

    Chapter

    Understanding and Engineering the Pulmonary Vasculature

    Blood vessels play essential roles in regulating embryonic organogenesis and adult tissue homeostasis. The inner lining of blood vessels is covered by vascular endothelial cells, which exhibit tissue-specific ...

    Wai Hoe Ng, Barbie Varghese, ** Ren in Engineering Translational Models of Lung H… (2023)

  4. No Access

    Chapter

    Hydrogel-Based Tissue-Mimics for Vascular Regeneration and Tumor Angiogenesis

    The vital role of structurally and functionally stable vasculature in engineered tissues is well-established in regenerative medicine. Large-volume, natural, and synthetic tissue constructs require a high degr...

    Sushmita Bist, Abhinaba Banerjee, Indira Priyadarshani Patra in Regenerative Medicine (2023)

  5. No Access

    Chapter

    Clinical Translation of Engineered Pulmonary Vascular Models

    Diseases in pulmonary vasculature remain a major cause of morbidity and mortality worldwide. Numerous pre-clinical animal models were developed to understand lung vasculature during diseases and development. H...

    Yifan Yuan in Engineering Translational Models of Lung Homeostasis and Disease (2023)

  6. No Access

    Chapter

    Current and Future Engineering Strategies for ECMO Therapy

    Extracorporeal membrane oxygenation (ECMO) is a last resort therapy for patients with respiratory failure where the gas exchange capacity of the lung is compromised. Venous blood is pumped through an oxygenati...

    Deniz A. Bölükbas, Sinem Tas in Engineering Translational Models of Lung H… (2023)

  7. No Access

    Chapter

    Mimicking Islet Development with Human Pluripotent Stem Cells

    The development of functional beta cells from human pluripotent stem cells (PSCs) offers a promising approach for treating type 1 diabetes (T1D). However, current differentiation protocols often yield heteroge...

    Aubrey L. Faust, Adrian Veres in Pluripotent Stem Cell Therapy for Diabetes (2023)

  8. No Access

    Chapter

    Bioactive Materials for Use in Stem Cell Therapies for the Treatment of Type 1 Diabetes

    Diabetes is a major challenge to healthcare providers globally, with significant human and financial costs. Type 1 diabetes is expected to effect more than a million people concurrently, with over 130,000 newl...

    Jonathan Hinchliffe, Ipsita Roy in Pluripotent Stem Cell Therapy for Diabetes (2023)

  9. No Access

    Chapter

    Simple Models of Lung Development

    Models are essential to further our understanding of lung development and regeneration and to facilitate identification and testing of potential treatments for lung diseases. A wide variety of rodent and human...

    Charlotte H. Dean, Sek-Shir Cheong in Engineering Translational Models of Lung H… (2023)

  10. Chapter

    Correction to: Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis

    Laertis Ikonomou, Maria Yampolskaya in Engineering Translational Models of Lung H… (2023)

  11. No Access

    Chapter

    Pancreatic Cell Fate Specification: Insights Into Developmental Mechanisms and Their Application for Lineage Reprogramming

    Adult differentiated cells can be forced to switch identities from one cell type to another under the direction of specific transcription factors (TF) in so-called direct lineage reprogramming. The ability to ...

    Sara Gonzalez Ortega, Anna Melati in Pluripotent Stem Cell Therapy for Diabetes (2023)

  12. No Access

    Chapter

    Immunogenicity of Stem Cell Derived Beta Cells

    One of the biggest challenges in beta cell replacement therapy of patients with type 1 diabetes relates to the cause of their disease: islet autoimmunity. The permanent immune suppressive therapy that is the c...

    Nicoline H. M. den Hollander, Bart O. Roep in Pluripotent Stem Cell Therapy for Diabetes (2023)

  13. No Access

    Chapter

    Regenerative Approaches in the Nervous System

    The nervous system is the most unique system of the human body in more than one way. The excitable tissue that forms the nervous system generates and transmits electrical impulses that are responsible for comm...

    Ronak Reshamwala, Megha Shah in Regenerative Medicine (2023)

  14. Chapter

    Multipotent Embryonic Lung Progenitors: Foundational Units of In Vitro and In Vivo Lung Organogenesis

    Transient, tissue-specific, embryonic progenitors are important cell populations in vertebrate development. In the course of respiratory system development, multipotent mesenchymal and epithelial progenitors d...

    Laertis Ikonomou, Maria Yampolskaya in Engineering Translational Models of Lung H… (2023)

  15. No Access

    Chapter

    The Promises of Pancreatic Progenitor Proliferation and Differentiation

    Human pluripotent stem cells (hPSCs) have been proposed as an unlimited source of insulin-secreting pancreatic β cells for diabetes treatment. Many laboratories have demonstrated that hPSCs such as human embry...

    Azuma Kimura, Kenji Osafune in Pluripotent Stem Cell Therapy for Diabetes (2023)

  16. No Access

    Chapter

    Islet Immunoengineering

    From 2000 to 2020, 2170 patients globally received islet allotransplants. Islet transplantation into the hepatic portal vein seeks to replace the insulin-producing β cells that are lost to autoimmunity in type...

    Leonor N. Teles, Chris M. Li in Pluripotent Stem Cell Therapy for Diabetes (2023)

  17. No Access

    Chapter

    Understanding LncRNAs in Biomaterials Development for Osteointegration

    Osseointegration of implants is a sophisticated healing process comprising of blood clot formation, immune response, angiogenesis, and osteogenesis. The features of the blood clots take a crucial role in fulfi...

    Yuyu Zhao, Long Bai, **aohong Yao, Ruiqiang Hang, Yin **ao in Regenerative Medicine (2023)

  18. No Access

    Chapter

    Computational, Ex Vivo, and Tissue Engineering Techniques for Modeling Large Airways

    The large airways are a critical component of the respiratory tree serving both an immunoprotective role and a physiological role for ventilation. The physiological role of the large airways is to move a large...

    Rebecca L. Heise in Engineering Translational Models of Lung Homeostasis and Disease (2023)

  19. No Access

    Chapter

    Scaffolds for Encapsulation of Stem Cell-Derived β Cells

    Currently, clinical islet transplantation is the most promising minimal invasive therapy to treat the most severe cases of type 1 diabetes, where exogenous insulin administration can no longer be used to contr...

    Rick de Vries, Aart A. van Apeldoorn in Pluripotent Stem Cell Therapy for Diabetes (2023)

  20. No Access

    Chapter

    Genetic Safety Switches for Pluripotent Stem Cell-Derived Therapies for Diabetes

    As human pluripotent stem cell (hPSC)-derived therapies move towards clinical application, ensuring the safety of transplanted cell populations remains a critical concern. Because undifferentiated hPSC are hig...

    Dena E. Cohen, Jon S. Odorico in Pluripotent Stem Cell Therapy for Diabetes (2023)

previous disabled Page of 4